BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8327702)

  • 1. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Burrowes P; Coleman RE; Goodman PC
    Radiology; 1993 Aug; 188(2):487-90. PubMed ID: 8327702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.
    Lowe VJ; DeLong DM; Hoffman JM; Coleman RE
    J Nucl Med; 1995 May; 36(5):883-7. PubMed ID: 7738668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy.
    Knight SB; Delbeke D; Stewart JR; Sandler MP
    Chest; 1996 Apr; 109(4):982-8. PubMed ID: 8635381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
    Lowe VJ; Hoffman JM; DeLong DM; Patz EF; Coleman RE
    J Nucl Med; 1994 Nov; 35(11):1771-6. PubMed ID: 7965154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Gupta NC; Frank AR; Dewan NA; Redepenning LS; Rothberg ML; Mailliard JA; Phalen JJ; Sunderland JJ; Frick MP
    Radiology; 1992 Aug; 184(2):441-4. PubMed ID: 1620844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
    Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
    AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
    Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
    Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
    Dewan NA; Reeb SD; Gupta NC; Gobar LS; Scott WJ
    Chest; 1995 Aug; 108(2):441-6. PubMed ID: 7634881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary abnormalities and PET data analysis: a retrospective study.
    Lowe VJ; Duhaylongsod FG; Patz EF; Delong DM; Hoffman JM; Wolfe WG; Coleman RE
    Radiology; 1997 Feb; 202(2):435-9. PubMed ID: 9015070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
    Gupta NC; Maloof J; Gunel E
    J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating benign and malignant pulmonary lesions with FDG-PET.
    Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY
    Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic FDG PET: state of the art.
    Erasmus JJ; McAdams HP; Patz EF; Goodman PC; Coleman RE
    Radiographics; 1998; 18(1):5-20. PubMed ID: 9460106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography.
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    Ann Thorac Surg; 1995 Nov; 60(5):1348-52. PubMed ID: 8526625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging.
    Keogan MT; Lowe VJ; Baker ME; McDermott VG; Lyerly HK; Coleman RE
    Abdom Imaging; 1997; 22(3):332-7. PubMed ID: 9107663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
    Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positron emission tomography (PET) with fludeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions].
    Maurea S; Mainolfi C; Wang H; Varrella P; Panico MR; Klain M; Rossi R; Cremona F; Bazzicalupo L; Salvatore M
    Radiol Med; 1996 Dec; 92(6):782-7. PubMed ID: 9122472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Worsley DF; Celler A; Adam MJ; Kwong JS; Müller NL; Coupland DB; Champion P; Finley RJ; Evans KG; Lyster DM
    AJR Am J Roentgenol; 1997 Mar; 168(3):771-4. PubMed ID: 9057532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of pulmonary lesions with positron emission tomography].
    Knopp MV; Bischoff HG
    Radiologe; 1994 Oct; 34(10):588-91. PubMed ID: 7816916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.